| Customization: | Available |
|---|---|
| Varieties: | Growth Promoting Medicine |
| Component: | Animal |
|
Still deciding? Get samples of US$ 80/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
|
|
Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by
Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small
animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
1. Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
2. Ponazuril have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
|
Items |
Standards |
Results |
|
Physical Analysis |
||
|
Description |
White Powder | Complies |
|
Assay |
99% | 99.6% |
|
Mesh Size |
100 % pass 80 mesh | Complies |
|
Ash |
≤ 5.0% | 2.85% |
|
Loss on Drying |
≤ 5.0% | 2.65% |
|
Chemical Analysis |
||
|
Heavy Metal |
≤ 10.0 mg/kg |
Complies |
|
Pb |
≤ 2.0 mg/kg |
Complies |
|
As |
≤ 1.0 mg/kg | Complies |
|
Hg |
≤ 0.1mg/kg | Complies |
|
Microbiological Analysis |
||
|
Residue of Pesticide |
Negative | Negative |
|
Total Plate Count |
≤ 1000cfu/g | Complies |
|
Yeast&Mold |
≤ 100cfu/g | Complies |
|
E.coil |
Negative |
Negative |
|
Salmonella |
Negative |
Negative |
){kind=link}